本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

PMV Pharmaceuticals

0.9389
-0.0577-5.79%
成交量:33.55万
成交额:32.38万
市值:4,876.05万
市盈率:-0.82
高:1.00
开:1.00
低:0.9386
收:0.9966
数据加载中...
2022/05/10

重要事件披露

8-K - Current report
2022/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/01

重要事件披露

8-K - Current report
2022/03/01

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/01/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/06

重要事件披露

8-K - Current report
2021/11/12

重要事件披露

8-K - Current report
2021/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/18

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals